GeneBioTech Co. Ltd (086060) — Cash Flow Quality Index
GeneBioTech Co. Ltd (086060) has a Cash Flow Quality Index of -0.18x as of June 2026. Operating cash flow of ₩-230.73 Million is below net income of ₩1.29 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore 086060 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
GeneBioTech Co. Ltd Cash Flow Quality Index (2009–2025)
Historical Cash Flow Quality Index for GeneBioTech Co. Ltd across 14 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see cash flow conversion of GeneBioTech Co. Ltd.
Annual Cash Flow Quality Index for GeneBioTech Co. Ltd (2009–2025)
Year-by-year earnings quality comparison for GeneBioTech Co. Ltd.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.01x | ₩7.61 Billion | ₩3.79 Billion | ▲ +1341.3% |
| 2024 | -0.16x | ₩-463.87 Million | ₩2.87 Billion | ▼ -105.7% |
| 2023 | 2.84x | ₩7.37 Billion | ₩2.59 Billion | ▲ +217.7% |
| 2022 | -2.42x | ₩-3.68 Billion | ₩1.52 Billion | ▲ +23.7% |
| 2019 | -3.17x | ₩-2.68 Billion | ₩846.78 Million | ▼ -242.7% |
| 2018 | 2.22x | ₩5.96 Billion | ₩2.68 Billion | ▲ +309.5% |
| 2017 | 0.54x | ₩1.13 Billion | ₩2.09 Billion | ▼ -74.1% |
| 2016 | 2.10x | ₩5.31 Billion | ₩2.53 Billion | ▼ -53.0% |
| 2015 | 4.46x | ₩2.61 Billion | ₩583.71 Million | ▲ +125.9% |
| 2014 | 1.98x | ₩2.15 Billion | ₩1.09 Billion | ▼ -83.1% |
| 2013 | 11.66x | ₩2.38 Billion | ₩203.94 Million | ▲ +152.7% |
| 2011 | 4.61x | ₩2.53 Billion | ₩547.78 Million | ▲ +322.2% |
| 2010 | 1.09x | ₩1.17 Billion | ₩1.07 Billion | ▼ -71.0% |
| 2009 | 3.77x | ₩2.68 Billion | ₩711.60 Million | — |